These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Enhanced cardiac sympathetic afferent reflex involved in sympathetic overactivity in renovascular hypertensive rats. Zhu GQ; Xu Y; Zhou LM; Li YH; Fan LM; Wang W; Gao XY; Chen Q Exp Physiol; 2009 Jul; 94(7):785-94. PubMed ID: 19346334 [TBL] [Abstract][Full Text] [Related]
29. Sympathetic nervous system and chronic renal failure. Boero R; Pignataro A; Ferro M; Quarello F Clin Exp Hypertens; 2001; 23(1-2):69-75. PubMed ID: 11270590 [TBL] [Abstract][Full Text] [Related]
30. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Rump LC; Amann K; Orth S; Ritz E Nephrol Dial Transplant; 2000 Nov; 15(11):1735-8. PubMed ID: 11071955 [No Abstract] [Full Text] [Related]
31. Adrenergic overdrive: a 'not-so-sympathetic' risk factor in renal failure patients. Jordan J; Grassi G J Hypertens; 2007 Jun; 25(6):1197-9. PubMed ID: 17563531 [No Abstract] [Full Text] [Related]
32. [Neural control of renal hemodynamics in essential hypertension]. Takishita S Nihon Rinsho; 2000 Jan; 58 Suppl 1():303-7. PubMed ID: 11026279 [No Abstract] [Full Text] [Related]
33. [Contemporary diagnosis of increased sympathetic activity: the ups and downs]. Luciak M Pol Arch Med Wewn; 2002 Apr; 107(4):345-7. PubMed ID: 12189926 [No Abstract] [Full Text] [Related]
34. Should beta-blockers be used to control hypertension in people with chronic kidney disease? Hart PD; Bakris GL Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793 [TBL] [Abstract][Full Text] [Related]
35. Renalase, a new renal hormone: its role in health and disease. Xu J; Desir GV Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):373-8. PubMed ID: 17565281 [TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of hypertension in chronic renal disease. Kincaid-Smith P; Whitworth JA Semin Nephrol; 1988 Jun; 8(2):155-62. PubMed ID: 3293139 [No Abstract] [Full Text] [Related]
37. Adrenergic nervous system in hypertension. Campese VM Contrib Nephrol; 1985; 49():145-55. PubMed ID: 3007023 [No Abstract] [Full Text] [Related]
38. Sympathetic hyperactivity influences chemosensor function in patients with end-stage renal disease. Meyer C; Schueller P; Balzer J; Lauer T; Westenfeld R; Schauerte P; Hennersdorf M; Steiner S; Kelm M; Rassaf T Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):151-5. PubMed ID: 20156747 [TBL] [Abstract][Full Text] [Related]
39. Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation. Rassaf T; Westenfeld R; Balzer J; Lauer T; Merx M; Floege J; Steiner S; Heiss C; Kelm M; Meyer C Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):83-7. PubMed ID: 21147628 [TBL] [Abstract][Full Text] [Related]
40. Proceedings of the Maastricht Symposium on Renal Nerves and Hypertension. Satellite symposium to the 11th scientific meeting of the International Society of Hypertension. Maastricht, The Netherlands, September 6-7, 1986. Clin Exp Hypertens A; 1987; 9 Suppl 1():1-326. PubMed ID: 3677448 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]